Anixa Biosciences (ANIX) Other Non-Current Liabilities (2013 - 2017)

Anixa Biosciences (ANIX) has reported Other Non-Current Liabilities for 5 consecutive years, with $4.3 million the latest figure, recorded in Q1 2017.

• For the quarter ending Q1 2017, Other Non-Current Liabilities rose 13.14% year-over-year to $4.3 million; the trailing twelve-month figure through Jan 2017 stood at $4.3 million (up 13.14% YoY), and the FY2016 full-year result was $4.2 million, up 13.11% from the prior year.
• Other Non-Current Liabilities advanced to $4.3 million in Q1 2017 per ANIX's latest filing, from $4.2 million in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $4.3 million in Q1 2017 and bottomed at $45600.0 in Q2 2013.
• Historically, Other Non-Current Liabilities has averaged $3.0 million across 5 years, with a median of $3.4 million in 2014.
• The sharpest annual moves came in 2014 and 2015: Other Non-Current Liabilities soared 6560.09% in 2014, then fell 2.46% in 2015.
• Over 5 years, Other Non-Current Liabilities stood at $540000.0 in 2013, then surged by 499.31% to $3.2 million in 2014, then gained by 13.96% to $3.7 million in 2015, then increased by 13.11% to $4.2 million in 2016, then rose by 3.39% to $4.3 million in 2017.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $4.3 million, $4.2 million, and $4.1 million for Q1 2017, Q4 2016, and Q3 2016 respectively.